Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Security class unavailable · CUSIP: 69353Y103
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,528,290
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-023842
- Form type
- SC 13G
- Filer
- Nextech V Oncology S.C.S., SICAV-SIF
- CIK
- CIK 1712922
- Filed
- Feb 16, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership